Global Diabetic Retinopathy Treatment Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 7.05 Billion |
Market Size (Forecast Year) |
USD 12.03 Billion |
CAGR |
|
Major Markets Players |
|
>全球糖尿病视网膜病变治疗市场,按治疗类型(激光手术、玻璃体切除术、眼内类固醇注射、抗血管内皮生长因子药物)、类型(非增生性、增生性)、设备类型(局部激光治疗、玻璃体切除设备、散射激光治疗)、严重程度(轻度、中度、重度)、药物类型(阿柏西普、贝伐单抗、氟轻松、雷珠单抗、曲安奈德注射液)、最终用户(医院、眼科诊所、门诊手术中心)划分 - 行业趋势和预测到 2030 年。
糖尿病视网膜病变治疗市场分析及规模
糖尿病是全球范围内的严重问题,胰腺无法有效产生胰岛素,导致血糖水平升高。糖尿病视网膜病变是糖尿病引起视网膜损伤的结果。全球糖尿病视网膜病变的患病率约为 22.27%。全球糖尿病患者的 DR 发病率预计为 27.0%。为诊断和改善疾病而推出的服务促进了该国市场的增长。此外,对抗 VEGF 药物的需求巨大,这也推动了市场的增长。
Data Bridge Market Research 分析,糖尿病视网膜病变治疗市场规模将从 2022 年的 70.5 亿美元增至 2030 年的 120.3 亿美元,预计在 2023 年至 2030 年的预测期内复合年增长率为 6.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
糖尿病视网膜病变治疗市场范围和细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021(可定制为 2015 - 2020) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
治疗类型(激光手术、玻璃体切除术、眼内类固醇注射、抗血管内皮生长因子药物)、类型(非增生性、增生性)、设备类型(局部激光治疗、玻璃体切除设备、散射激光治疗)、严重程度(轻度、中度、重度)、药物类型(阿柏西普、贝伐单抗、氟轻松、雷珠单抗、曲安奈德注射液)、最终用户(医院、眼科诊所、门诊手术中心) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、欧洲的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
Bayer AG (Germany), Aurobindo Pharma (India), AbbVie Inc. (U.S.), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Bausch Health Companies Inc. (U.S.), Accord Healthcare (U.K.), Genentech, Inc (U.S.)., Regeneron Pharmaceuticals Inc (U.S.), Abbott (U.S.), Kowa Pharmaceuticals America, Inc. (U.S.)., Ampio Pharmaceuticals Inc. (U.S.)., Lumenis Be Ltd (Israel), Alimera Sciences Europe Ltd (U.S.), Glycadia, Inc (U.S.), Oxurion NV (Belgium) |
Market Opportunities |
|
Market Definition
Diabetic retinopathy (DR) is the most common diabetic eye disease and is a top cause of blindness in people with diabetes. It is mainly caused by fluctuations in blood glucose levels leading to abnormal growth in the light-sensitive tissues present in the eye. When this fluid leaks, it causes the macula to swell or thicken, leading to vision loss. This disease is commonly witnessed in children aged 20 to 74 years.
Global Diabetic Retinopathy Treatment Market Dynamics
Drivers
- Increasing Collaborations Associated with Diabetic Retinopathy Treatment
Numerous collaborations are associated with diabetic retinopathy that leads to market growth. For Instance, Eyenuk, Inc, in collaboration with Discovery Health, has launched a new Diabetic Retinopathy Screening Benefit nationwide in South Africa, powered by the cutting-edge EyeArt Artificial Intelligent System in 2021. It helps in allowing the detection of the onset of diabetic retinopathy very quickly. This factor leads to the growth of the market.
- Increasing Prevalence of Diabetes
The growing burden of diabetes is boosting the growth of the market. According to "Diabetic retinopathy screening: a short guide," published by WHO in 2020, the incidence of any retinopathy in people with diabetes is 35%, whereas proliferative (vision-threatening) retinopathy is around 7%. Furthermore, the International Diabetes Federation Diabetes Atlas, 10th edition 2021, stated that in 2021, there would be about 536,600,000 people with diabetes globally, and it is expected to reach 783,700,000 by the year 2045. This increasing burden of diabetes surges the risk of diabetic retinopathy and is therefore anticipated to drive market growth. Thus, this factor help in the market growth.
Opportunities
- Growing Research Activities by Market Players
The increasing research and development activities for developing effective diagnostic and therapeutic methods for diabetic retinopathy will enhance segment growth. For instance, in "Mi-RNA-93 and Mi-RNA-152 in the Diagnosis of Type 2 Diabetes and Diabetic Retinopathy," published in 2022, MiR-93 and miR-152 can differentiate between patients who have diabetes and those with diabetic retinopathy. Both miRNAs can be potential biomarkers for diabetes and diabetic retinopathy, mainly for proliferative diabetic retinopathy. Thus, this factor boosts market growth.
- Increasing Demand for Anti-VEGF Drugs
The increasing demand for anti-VEGF drugs is due to their efficiency and efficacy in treating diabetic retinopathy. The anti-VEGF drugs are commonly used to treat Proliferative Diabetic Retinopathy (PDR). Furthermore, these drugs were more beneficial than others, mainly in patients suffering from a vitreous hemorrhage, neovascular glaucoma, and before the vitrectomy procedure. Thus, this factor is a major factor that increases market growth.
Restraints/Challenges
- High Cost of Diabetic Retinopathy Treatment
The severe cost of treatment and diagnostic procedures associated with diabetic retinopathy hinders the market. Several procedures are costly and cannot be afforded by underdeveloped and developing countries. Thus, this factor impedes market growth.
- Side Effects of Diabetic Retinopathy Treatment
There are several side effects that are associated with diabetic retinopathy treatment that causes market hindrance. There's also a risk of blood clots to form, which could cause heart attack or stroke. Other effects such as macular edema, visual field deficits, exudative retinal detachments, and night vision defects can be witnessed. Thus, this factor impede the market growth.
This diabetic retinopathy treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diabetic retinopathy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, Eyenuk, Inc in collaboration with Discovery Health has launched a new Diabetic Retinopathy Screening Benefit in South Africa, which is powered by the cutting-edge EyeArt Artificial Intelligent System. It helps in allowing the detection of the onset of diabetic retinopathy rapidly.
Global Diabetic Retinopathy Treatment Market Scope
The diabetic retinopathy treatment market is segmented on the basis of treatment type, type, device type, severity, drug type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment Type
- Laser Surgery
- Vitrectomy
- Intraocular Steroid Injection
- Anti-Vascular Endothelial Growth Factor Drug
Type
- Non-Proliferative
- Proliferative
Device Type
- Focal Laser Treatment
- Vitrectomy Devices
- Scatter Laser Treatment
Severity Type
- Mild
- Moderate
- Severe
Drug Type
- Aflibercept
- Bevacizumab
- Fluocinolone
- Ranibizumab
- Triamcinolone Acetonide Injection
End User
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
Diabetic Retinopathy Treatment Market Regional Analysis/Insights
The diabetic retinopathy treatment market is analyzed and market size insights and trends are provided by treatment type, type, device type, severity, drug type, and end user as referenced above.
The countries covered in the diabetic retinopathy treatment market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to grow during the forecast period diabetic retinopathy treatment market because of the well-established veterinary healthcare infrastructure in the region. Also, the wide presence of top porcine production countries, such as China, and a large meat-consuming population, are boosting the market growth.
North America dominates the market in the forecast due to the increasing market dominance of avastin, eylea, and lucentis, which are anti-VEGF drugs, and also the largest share due to the supportive reimbursement policies. Furthermore, the growing incidence of diabetes in this region also boosts the market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The diabetic retinopathy treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for diabetic retinopathy treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diabetic retinopathy treatment market. The data is available for historic period 2011-2021.
Competitive Landscape and Diabetic Retinopathy Treatment Market Share Analysis
糖尿病视网膜病变治疗市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对糖尿病视网膜病变治疗市场的关注有关。
糖尿病视网膜病变治疗市场的一些主要参与者包括:
- 拜耳公司(德国)
- Aurobindo Pharma(印度)
- AbbVie Inc.(美国)
- 诺华公司(瑞士)
- F. Hoffmann-La Roche Ltd(瑞士)
- Bausch Health Companies Inc.(美国)
- Accord Healthcare(英国)
- Genentech, Inc(美国)。
- Regeneron Pharmaceuticals Inc(美国)。
- 雅培(美国)
- Kowa Pharmaceuticals America, Inc.(美国)
- Ampio Pharmaceuticals Inc.(美国)。
- Lumenis Be Ltd(以色列)
- Alimera Sciences Europe Ltd(美国)
- Glycadia, Inc(美国)
- Oxurion NV(比利时)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.